Contribution of Bordetella filamentous hemagglutinin and adenylate cyclase toxin to suppression and evasion of interleukin-17-mediated inflammation

Infection and Immunity

Volumn 80, Issue 6, 2012, Pages 2061-2075

  Henderson, Michael W ^a   Inatsuka, Carol S ^b   Sheets, Amanda J ^a   Williams, Corinne L ^b   Benaron, David J ^b   Donato, Gina M ^c   Gray, Mary C ^c   Hewlett, Erik L ^c   Cotter, Peggy A ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE TOXIN; FILAMENTOUS HEMAGGLUTININ; HEMAGGLUTININ; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ADHESIN; BORDETELLA VIRULENCE FACTOR; CYTOKINE; FHA PROTEIN, BORDETELLA BRONCHISEPTICA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BORDETELLA BRONCHISEPTICA; BORDETELLA PERTUSSIS; BORDETELLOSIS; CATALYSIS; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; IMMUNE EVASION; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; MACROPHAGE; NEUTROPHIL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INFLAMMATION; LUNG; METABOLISM; MICROBIOLOGY; MOUSE; PATHOLOGY; PHYSIOLOGY; TIME;

ADENYLATE CYCLASE TOXIN; ADHESINS, BACTERIAL; ANIMALS; BORDETELLA BRONCHISEPTICA; CELL LINE; CYTOKINES; GENE EXPRESSION REGULATION; INFLAMMATION; INTERLEUKIN-17; LUNG; MACROPHAGES; MICE; MICE, INBRED BALB C; TIME FACTORS; VIRULENCE FACTORS, BORDETELLA;

EID: 85047687134     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00148-12     Document Type: Article

References (74)

1. Abramson T, Kedem H, Relman DA. 2008. Modulation of the NF-κB pathway by Bordetella pertussis filamentous hemagglutinin. PLoS One 3:e3825.
2. Akerley BJ, Cotter PA, Miller JF. 1995. Ectopic expression of the flagellar regulon alters development of the Bordetella-host interaction. Cell 80: 611-620.
3. Andreasen C, Powell DA, Carbonetti NH. 2009. Pertussis toxin stimulates IL-17 production in response to Bordetella pertussis infection in mice. PLoS One 4:e7079.
4. Ausiello CM, et al. 2000. Cell-mediated immunity and antibody re-sponses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine. J. Infect. Dis. 181:1989 -1995.
5. Bagley KC, Abdelwahab SF, Tuskan RG, Fouts TR, Lewis GK. 2002. Pertussis toxin and the adenylate cyclase toxin from Bordetella pertussis activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cAMP-dependent pathway. J. Leukoc. Biol. 72:962-969.
6. Banus HA, et al. 2006. Host genetics of Bordetella pertussis infection in mice: significance of Toll-like receptor 4 in genetic susceptibility and pathobiology. Infect. Immun. 74:2596 -2605.
7. Barry EM, et al. 1991. Bordetella pertussis adenylate cyclase toxin and hemolytic activities require a second gene, cyaC, for activation. J. Bacteriol. 173:720 -726.
8. Bassinet L, et al. 2000. Role of adhesins and toxins in invasion of human tracheal epithelial cells by Bordetella pertussis. Infect. Immun. 68:1934- 1941.
9. Bemis DA. 1992. Bordetella and Mycoplasma respiratory infections in dogs and cats. Vet. Clin. North Am. 22:1173-1186.
10. Bemis DA, Shek WR, Clifford CB. 2003. Bordetella bronchiseptica infection of rats and mice. Comp. Med. 53:11-20.
11. Betsou F, Sebo P, Guiso N. 1995. The C-terminal domain is essential for protective activity of the Bordetella pertussis adenylate cyclase-hemolysin. Infect. Immun. 63:3309 -3315.
12. Bettelli E, Korn T, Oukka M, Kuchroo VK. 2008. Induction and effector functions of T(H)17 cells. Nature 453:1051-1057.
13. Boyd AP, et al. 2005. Bordetella pertussis adenylate cyclase toxin modulates innate and adaptive immune responses: distinct roles for acylation and enzymatic activity in immunomodulation and cell death. J. Immunol. 175:730 -738.
14. Cheng SC, et al. Candida albicans dampens host defense by downregulating IL-17 production. J. Immunol. 185:2450 -2457.
15. Confer DL, Eaton JW. 1982. Phagocyte impotence caused by an invasive bacterial adenylate cyclase. Science 217:948 -950.
16. Cotter PA, Miller JF. 1994. BvgAS-mediated signal transduction: analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model. Infect. Immun. 62:3381-3390.
17. Cotter PA, et al. 1998. The filamentous hemagglutinin (FHA) of Bordetella bronchiseptica is required for efficient establishment of tracheal colonization. Infect. Immun. 66:5921-5929.
18. Curtis MM, Way SS. 2009. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 126:177-185.
19. Diavatopoulos DA, et al. 2005. Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica. PLoS Pathog. 1:e45.
20. Dunne A, et al. 2010. Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis. J. Immunol. 185:1711-1719.
21. El-Azami-El-Idrissi M, et al. 2003. Interaction of Bordetella pertussis adenylate cyclase with CD11b/CD18: role of toxin acylation and identification of the main integrin interaction domain. J. Biol. Chem. 278:38514- 38521.
22. Fedele G, et al. 2008. Lipopolysaccharides from Bordetella pertussis and Bordetella parapertussis differently modulate human dendritic cell functions resulting in divergent prevalence of Th17-polarized responses. J. Immunol. 181:208 -216.
23. Fedele G, et al. 2010. Bordetella pertussis commits human dendritic cells to promote a Th1/Th17 response through the activity of adenylate cyclase toxin and MAPK-pathways. PLoS One 5:e8734.
24. Geurtsen J, et al. 2009. Identification of a novel lipopolysaccharide core biosynthesis gene cluster in Bordetella pertussis, and influence of core structure and lipid A glucosamine substitution on endotoxic activity. Infect. Immun. 77:2602-2611.
25. Geurtsen J, et al. 2006. Expression of the lipopolysaccharide-modifying enzymes PagP and PagL modulates the endotoxic activity of Bordetella pertussis. Infect. Immun. 74:5574 -5585.
26. Goodnow RA. 1980. Biology of Bordetella bronchiseptica. Microbiol. Rev. 44:722-738.
27. Gray MC, Donato GM, Jones FR, Kim T, Hewlett EL. 2004. Newly secreted adenylate cyclase toxin is responsible for intoxication of target cells by Bordetella pertussis. Mol. Microbiol. 53:1709 -1719.
28. 2 integrin (CD11b/CD18). J. Exp. Med. 193:1035-1044.
29. Hackett M, Guo L, Shabanowitz J, Hunt DF, Hewlett EL. 1994. Internal lysine palmitoylation in adenylate cyclase toxin from Bordetella pertussis. Science 266:433- 435.
30. Hafler JP, Pohl-Koppe A. 1998. The cellular immune response to Bordetella pertussis in two children with whooping cough. Eur. J. Med. Res. 3:523-526.
31. Harvill ET, Cotter PA, Miller JF. 1999. Pregenomic comparative analysis between Bordetella bronchiseptica RB50 and Bordetella pertussis Tohama I in murine models of respiratory tract infection. Infect. Immun. 67:6109- 6118.
32. Harvill ET, Cotter PA, Miller JF. 1999. Probing the function of a bacterial virulence factor by manipulating host immunity. Infect. Immun. 67: 1493-1500.
33. Hickey FB, Brereton CF, Mills KH. 2008. Adenylate cycalse toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation in dendritic cells. J. Leukoc. Biol. 84:234 -243.
34. Hirota K, Martin B, Veldhoen M. 2010. Development, regulation and functional capacities of Th17 cells. Semin. Immunopathol. 32:3-16.
35. Hoshino A, et al. 2008. MPO-ANCA induces IL-17 production by activated neutrophils in vitro via classical complement pathway-dependent manner. J. Autoimmun. 31:79-89.
36. Inatsuka CS, Julio SM, Cotter PA. 2005. Bordetella filamentous hemagglutinin plays a critical role in immunomodulation, suggesting a mechanism for host specificity. Proc. Natl. Acad. Sci. U. S. A. 102:18578 -18583.
37. Inatsuka CS, et al. 2010. Pertactin is required for Bordetella species to resist neutrophil-mediated clearance. Infect. Immun. 78:2901-2909.
38. Ishibashi Y, Claus S, Relman DA. 1994. Bordetella pertussis filamentous hemagglutinin interacts with a leukocyte signal transduction complex and stimulates bacterial adherence to monocyte CR3 (CD11b/CD18). J. Exp. Med. 180:1225-1233.
39. Jacob-Dubuisson F, et al. 1996. Amino-terminal maturation of the Bordetella pertussis filamentous haemagglutinin. Mol. Microbiol. 19:65-78.
40. Julio SM, et al. 2009. Natural-host animal models indicate functional interchangeability between the filamentous haemagglutinins of Bordetella pertussis and Bordetella bronchiseptica and reveal a role for the mature C-terminal domain, but not the RGD motif, during infection. Mol. Microbiol. 71:1574 -1590.
41. Laan M, et al. 1999. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J. Immunol. 162:2347-2352.
42. Li L, et al. 2010. IL-17 produced by neutrophils regulates IFN-gammamediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J. Clin. Invest. 120:331-342.
43. Locht C, Bertin P, Menozzi FD, Renauld G. 1993. The filamentous haemagglutinin, a multifaceted adhesion produced by virulent Bordetella spp. Mol. Microbiol. 9:653- 660.
44. Mann PB, Elder KD, Kennett MJ, Harvill ET. 2004. Toll-like receptor 4-dependent early elicited tumor necrosis factor alpha expression is critical for innate host defense against Bordetella bronchiseptica. Infect. Immun. 72:6650-6658.
45. Mann PB, Kennett MJ, Harvill ET. 2004. Toll-like receptor 4 is critical to innate host defense in a murine model of bordetellosis. J. Infect. Dis. 189:833- 836.
46. Marr N, et al. 2010. Substitution of the Bordetella pertussis lipid A phosphate groups with glucosamine is required for robust NF-κB activation and release of proinflammatory cytokines in cells expressing human but not murine Toll-like receptor 4-MD-2-CD14. Infect. Immun. 78:2060- 2069.
47. Mascart F, et al. 2003. Bordetella pertussis infection in 2-month-old infants promotes type 1 T cell responses. J. Immunol. 170:1504 -1509.
48. Mattoo S, Cherry JD. 2005. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev. 18:326 -382.
49. Mattoo S, Miller JF, Cotter PA. 2000. Role of Bordetella bronchiseptica fimbria in tracheal colonization and development of a humoral immune response. Infect. Immun. 68:2024 -2033.
50. Mazar J, Cotter PA. 2007. New insight into the molecular mechanisms of two-partner secretion. Trends Microbiol. 15:508 -515.
51. Mazar J, Cotter PA. 2006. Topology and maturation of filamentous haemagglutinin suggest a new model for two-partner secretion. Mol. Microbiol. 62:641- 654.
52. McGuirk P, McCann C, Mills KH. 2002. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195:221-231.
53. McGuirk P, Mills KH. 2000. Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin from Bordetella pertussis. Eur. J. Immunol. 30:415- 422.
54. Mills KH. 2001. Immunity to Bordetella pertussis. Microbes Infect. 3:655- 677.
55. Parkhill J, et al. 2003. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat. Genet. 35:32- 40.
56. Perez Vidakovics ML, Lamberti Y, van der Pol WL, Yantorno O, Rodriguez ME. 2006. Adenylate cyclase influences filamentous haemagglutinin-mediated attachment of Bordetella pertussis to epithelial alveolar cells. FEMS Immunol. Med. Microbiol. 48:140 -147.
57. Perkins DJ, Gray MC, Hewlett EL, Vogel SN. 2007. Bordetella pertussis adenylate cyclase toxin (ACT) induces cyclooxygenase-2 (COX-2) in murine macrophages and is facilitated by ACT interaction with CD11b/CD18 (Mac-1). Mol. Microbiol. 66:1003-1015.
58. Pulendran B. 2004. Modulating TH1/TH2 responses with microbes, dendritic cells, and pathogen recognition receptors. Immunol. Res. 29:187- 196.
59. Romani L, Zelante T, De Luca A, Fallarino F, Puccetti P. 2008. IL-17 and therapeutic kynurenines in pathogenic inflammation to fungi. J. Immunol. 180:5157-5162.
60. Ross PJ, Lavelle EC, Mills KH, Boyd AP. 2004. Adenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells. Infect. Immun. 72:1568 -1579.
61. Siciliano NA, Skinner JA, Yuk MH. 2006. Bordetella bronchiseptica modulates macrophage phenotype leading to the inhibition of CD4 T cell proliferation and the initiation of a Th17 immune response. J. Immunol. 177:7131-7138.
62. Sisti F, et al. 2011. A deep rough type structure in Bordetella bronchiseptica lipopolysaccharide modulates host immune responses. Microbiol. Immunol. 55:847- 854.
63. Stainer DW, Scholte MJ. 1970. A simple chemically defined medium for the production of phase I Bordetella pertussis. J. Gen. Microbiol. 63:211- 220.
64. Urisu A, Cowell JL, Manclark CR. 1986. Filamentous hemagglutinin has a major role in mediating adherence of Bordetella pertussis to human WiDr cells. Infect. Immun. 52:695-701.
65. Vandebriel RJ, et al. 2003. Association of Bordetella pertussis with host immune cells in the mouse lung. Microbial pathogenesis. 35:19 -29.
66. van den Berg BM, Beekhuizen H, Willems RJ, Mooi FR, van Furth R. 1999. Role of Bordetella pertussis virulence factors in adherence to epithelial cell lines derived from the human respiratory tract. Infect. Immun. 67:1056 -1062.
67. Vojtova J, Kamanova J, Sebo P. 2006. Bordetella adenylate cyclase toxin: a swift saboteur of host defense. Curr. Opin. Microbiol. 9:69 -75.
68. Weiss AA, Falkow S. 1983. Transposon insertion and subsequent donor formation promoted by Tn501 in Bordetella pertussis. J. Bacteriol. 153: 304-309.
69. Weiss AA, Hewlett EL, Myers GA, Falkow S. 1985. Genetic studies of the molecular basis of whooping cough. Dev. Biol. Stand. 61:11-19.
70. Wolfe DN, Buboltz AM, Harvill ET. 2009. Inefficient Toll-like receptor-4 stimulation enables Bordetella parapertussis to avoid host immunity. PLoS One 4:e4280.
71. Wolff J, Cook GH, Goldhammer AR, Berkowitz SA. 1980. Calmodulin activates prokaryotic adenylate cyclase. Proc. Natl. Acad. Sci. U. S. A. 77: 3841-3844.
72. Wood N, Isaacs D. 2006. Monitoring vaccine reactions in Australia. Med. J. Aust. 184:150.
73. Ye P, et al. 2001. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am. J. Respir. Cell Mol. Biol. 25:335-340.
74. Zaretzky FR, Gray MC, Hewlett EL. 2002. Mechanism of association of adenylate cyclase toxin with the surface of Bordetella pertussis: a role for toxin-filamentous haemagglutinin interaction. Mol. Microbiol. 45:1589- 1598.